Home
Home

Indenix

Buyout Buzz: The most frequently cited takeover targets in biotech

Buyout Buzz: The most frequently cited takeover targets in biotech
Fierce Biotech

Idenix tumbles on hepatitis drug safety concerns

Idenix tumbles on hepatitis drug safety concerns
Yahoo/AP

IDX719 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection

IDX719 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection
Yahoo

Positive Data Released On Idenix Pharmaceuticals IDX184 Hep C Drug

Positive Data Released On Idenix Pharmaceuticals IDX184 Hep C Drug
Seeking Alpha

Keryx and Peers are Strong Buys

Keryx and Peers are Strong Buys
Motley Fool

Vertex Hopes Two Cystic Fibrosis Drugs Better than One

Vertex Hopes Two Cystic Fibrosis Drugs Better than One
TheStreet.com

Why Idenix Pharmaceuticals Could Dive Further

Why Idenix Pharmaceuticals Could Dive Further
Motley Fool

Bio-Pharma Watch List: 2 Week Report Card

Bio-Pharma Watch List: 2 Week Report Card
Seeking Alpha

A Bio-Pharma Watch List For This Week: 4 Buys, 1 Sell

A Bio-Pharma Watch List For This Week: 4 Buys, 1 Sell
Seeking Alpha

[video] Idenix Pharmaceuticals Is Looking For Partners

[video] Idenix Pharmaceuticals Is Looking For Partners
TheStreet.com